Article · 31 Oct 2026
ArticlePublished 30 Sep 2025
Does the mean heart dose remain a valid parameter for assessing early cardiac toxicity following radiotherapy for left-sided breast cancer?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Context: Adjuvant radiotherapy for left-sided breast cancer improves locoregional control and overall survival. However, irradiation of the cardiac structures increases the risk of radiation-induced cardiotoxicity. The mean heart dose (MHD) is commonly used to estimate this risk, but it does not reflect heterogeneous dose distribution within critical substructures, such as the left ventricle (LV) and left anterior descending artery (LAD). Purpose This study aimed to analyze the dose distribution within cardiac substructures and evaluate the reliability of mean heart dose (MHD) in predicting early radiation-induced myocardial dysfunction. Methods: Fifty patients with left-sided breast cancer who underwent three-dimensional conformal radiotherapy (3D-CRT) at Ibn Rochd University Hospital between 2020 and 2022 were analyzed. The target volumes and cardiac substructures were delineated. The dosimetric parameters of the heart, left ventricle (LV), left anterior descending artery (LAD), and other coronary arteries were statistically evaluated. Echocardiographic assessments, including speckle-tracking imaging, were performed before and after radiotherapy, to detect early myocardial alterations. Results: The mean heart dose (MHD) was 4.9 ± 0.8 Gy, while the left ventricle (LV) received a mean dose of 7.7 ± 2.1 Gy. The left anterior descending artery (LAD) was the most exposed structure with a mean dose of 25.9 ± 3.4 Gy. Pearson correlation analysis revealed a strong association between MHD and the mean LV dose (r = 0.742, p < 0.001), but a weaker correlation with the mean LAD dose (r = 0.460, p < 0.001). Regression analysis demonstrated that MHD had a low predictive value for LAD exposure (R² = 0.21) and moderate predictive value for LV dose (R² = 0.55). Echocardiographic assessment revealed segmental strain impairment in 23% of the patients within the LAD-perfused myocardial territory. The mean LAD dose was significantly higher in the patients with segmental strain abnormalities (30.19 Gy vs. 21 Gy, p = 0.004). In contrast, no significant association was found between MHD and strain abnormalities (p = 0.504). Conclusion: This study demonstrated that the mean heart dose (MHD) is insufficient to accurately assess cardiovascular risk in left-sided breast radiotherapy because it underestimates the actual exposure of the left ventricle and left anterior descending artery (LAD). Therefore, these substructures should be considered distinct organs at risk, and specific dosimetric constraints should be applied to better prevent radiation-induced cardiac complications. Moreover, the use of IMRT techniques, respiratory motion management, and early implementation of strain imaging warrants particular attention to optimize the management of high-risk patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Onkologia i Radioterapia.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOnkologia i Radioterapia
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Nezha Tawfiq”
- BylineArticles whose byline prints “Salma Guendaoui”
- BylineArticles whose byline prints “Meriem Tantaoui”
- BylineArticles whose byline prints “Karima Bendahhou”
- BylineArticles whose byline prints “Ghita Hatim”
- BylineArticles whose byline prints “Tarik Chekrine”
- BylineArticles whose byline prints “Meryem Belhouari”
- BylineArticles whose byline prints “Mouna Boughafour”